Today, we’re thrilled to introduce you to a man with what might be one of the most intriguing jobs in the brewing industry – yeast hunter Juan Ignacio Eizaguirre. Born in Buenos Aires, Argentina, with roots in the Basque Country, Juan has traveled the world in search of wild yeast, uncovering the secrets of fermentation. From the forests of Patagonia to ancient beer caves in Germany, he has dedicated his career to exploring the biological foundations of beer and pushing the boundaries of brewing science. Currently based in Bavaria at the world-renowned Weihenstephan, Juan is part scientist, part adventurer, and a true pioneer in discovering how yeast shapes the beers we love.

In this episode, Juan takes us on a journey through his work and passion – mapping yeast diversity, uncovering the mysteries of ancient strains like Saccharomyces eubayanus, and transforming his findings into innovations for brewers worldwide. He also shares his experiences in Argentina's thriving craft beer scene, his adventures in South America, and what it’s really like to hunt for yeast in some of the most remote and historic locations on the planet. So grab your favorite beer and join us as we delve into the incredible stories, science, and spirit of the yeast hunter, Juan Ignacio Eizaguirre...

BierTalk English 35

Imagine a future where we not only live longer but stay healthy throughout those extra years. Thanks to recent breakthroughs in biotechnology and artificial intelligence (AI) in healthcare, this vision is closer to becoming a reality.

Advancements in Aging Research

Aging research has made significant progress in recent years by combining disciplines like biology, technology, and medicine to tackle the challenges of extending healthspans and reducing age-related diseases. While people today live longer than ever before, extending our “healthspan”—the years we stay active and illness-free—remains challenging. AI and health biomarkers (biological indicators of our body’s condition) are now key tools in the pursuit of longer, healthier lives.

In a recent paper, led by corresponding authors Yu-Xuan Lyu from Southern University of Science and Technology Shenzhen; Alex Zhavoronkov from Insilico Medicine AI Limited, Masdar City, Abu Dhabi; Morten Scheibye-Knudsen and Daniela Bakula from the Center for Healthy Aging, University of Copenhagen, along with numerous other collaborators, the transformative potential of AI in aging research was explored. The research paper, titled “Longevity biotechnology: bridging AI, biomarkers, geroscience and clinical applications for healthy longevity,” was published as the cover paper in Aging’s Volume 16, Issue 20.

Full blog - https://aging-us.org/2024/11/how-ai-and-longevity-biotechnology-are-revolutionizing-healthcare-for-healthier-longer-lives/

Paper DOI - https://doi.org/10.18632/aging.206135

Corresponding authors - Yu-Xuan Lyu - lvyx@sustech.edu.cn, Alex Zhavoronkov - alex@insilico.com, Morten Scheibye-Knudsen - mscheibye@sund.ku.dk, and Daniela Bakula - bakula@sund.ku.dk

Video short - https://www.youtube.com/watch?v=Hpfe5WJ5g7I

Sign up for free Altmetric alerts about this article - 
https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206135

Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts

Keywords - aging, biotechnology, artificial intelligence, healthy longevity

About Aging-US

The mission of the journal is to understand the mechanisms surrounding aging and age-related diseases, including cancer as the main cause of death in the modern aged population.

The journal aims to promote 1) treatment of age-related diseases by slowing down aging, 2) validation of anti-aging drugs by treating age-related diseases, and 3) prevention of cancer by inhibiting aging. (Cancer and COVID-19 are age-related diseases.)

Please visit our website at https://www.Aging-US.com​​ and connect with us:

Facebook - https://www.facebook.com/AgingUS/
X - https://twitter.com/AgingJrnl
Instagram - https://www.instagram.com/agingjrnl/
YouTube - https://www.youtube.com/@AgingJournal
LinkedIn - https://www.linkedin.com/company/aging/
Pinterest - https://www.pinterest.com/AgingUS/
Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc

MEDIA@IMPACTJOURNALS.COM

Aging (Aging-US)

How AI and Longevity Biotechnology are Revolutionizing Healthcare for Healthier, Longer Lives

Drs. Alex Zhavoronkov, Morten Scheibye-Knudsen, Evelyne Bischof and Dominika Wilczok discuss a research paper they co-authored that was published as the cover of Aging (Aging-US) Volume 16, Issue 20, entitled, “Longevity biotechnology: bridging AI, biomarkers, geroscience and clinical applications for healthy longevity.”

DOI - https://doi.org/10.18632/aging.206135

Corresponding Authors - Yu-Xuan Lyu - lvyx@sustech.edu.cn, Alex Zhavoronkov - alex@insilico.com, Morten Scheibye-Knudsen - mscheibye@sund.ku.dk, and Daniela Bakula - bakula@sund.ku.dk

Video interview - https://www.youtube.com/watch?v=2nqvJ8cn5Fg

Video transcript - https://www.aging-us.com/interviews/longevity-biotechnology-ai-biomarkers-geroscience-for-healthy-aging

Sign up for free Altmetric alerts about this article - 
https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206135

Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts

Keywords - aging, biotechnology, artificial intelligence, healthy longevity

About Aging-US

The mission of the journal is to understand the mechanisms surrounding aging and age-related diseases, including cancer as the main cause of death in the modern aged population.

The journal aims to promote 1) treatment of age-related diseases by slowing down aging, 2) validation of anti-aging drugs by treating age-related diseases, and 3) prevention of cancer by inhibiting aging. (Cancer and COVID-19 are age-related diseases.)

Please visit our website at https://www.Aging-US.com​​ and connect with us:

Facebook - https://www.facebook.com/AgingUS/
X - https://twitter.com/AgingJrnl
Instagram - https://www.instagram.com/agingjrnl/
YouTube - https://www.youtube.com/@AgingJournal
LinkedIn - https://www.linkedin.com/company/aging/
Pinterest - https://www.pinterest.com/AgingUS/
Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc

MEDIA@IMPACTJOURNALS.COM

Behind the Study: Longevity Biotechnology - AI, Biomarkers & Geroscience for Healthy Aging

This lecture is entitled Quandaries of Biotechnology: Theory and Practice - Session 1.

It was presented by Kyle Karches of Saint Louis University and Stephen Meredith of the University of Chicago on March 22, 2024, at the University of Chicago.

Quandaries of Biotechnology: Theory and Practice - Session 1

This lecture is entitled Quandaries of Biotechnology: Theory and Practice - Session 2.

It was presented by Lesley Rice of the Pontifical John Paul II Institute and Silvianne Aspray of Cambridge University on March 22, 2024, at the University of Chicago.

Quandaries of Biotechnology: Theory and Practice - Session 2

This lecture is entitled Populations, Persons, and Precision Medicine: The Ethics of Emerging Information Technologies.

It was presented by Paul Scherz of (then) the University of Virginia on March 22, 2024, at the University of Chicago.

Populations, Persons, and Precision Medicine: The Ethics of Emerging Information Technologies

The microbiome represents an assemblage of a complex community of microbes (bacteria,
archaea, fungi, algae, protists, and viruses) and their biomolecules occupying a well-defined
habitat in or on a living or non-living object. Symbiotic microorganisms inhabiting the
gastrointestinal tract promote health by decreasing susceptibility to infection and enhancing
resistance to a range of diseases.

Microbiome Based Therapy

In the Season 3 premiere of the Longevity & Aging Series, Dr. Yu-Xuan Lyu from Southern University of Science and Technology (Shenzhen, China) joins host Dr. Evgeniy Galimov to discuss his co-authored research paper, featured as the cover for Aging (Aging-US) Volume 16, Issue 20, titled “Longevity biotechnology: bridging AI, biomarkers, geroscience, and clinical applications for healthy longevity.”
#aging #author #interview #series #biotechnology #ai #artificialintelligence #longevity #healthspan #lifespan #oa #openscience #peerreview #journal #publication #publishing #meded #agingshort #video

DOI - https://doi.org/10.18632/aging.206135

Corresponding authors - Yu-Xuan Lyu - lvyx@sustech.edu.cn, Alex Zhavoronkov - alex@insilico.com, Morten Scheibye-Knudsen - mscheibye@sund.ku.dk, and Daniela Bakula - bakula@sund.ku.dk

Video interview - https://www.youtube.com/watch?v=VUfNxWdBV5k

Video short - https://www.youtube.com/watch?v=Hpfe5WJ5g7I

Abstract

The recent unprecedented progress in ageing research and drug discovery brings together fundamental research and clinical applications to advance the goal of promoting healthy longevity in the human population. We, from the gathering at the Aging Research and Drug Discovery Meeting in 2023, summarised the latest developments in healthspan biotechnology, with a particular emphasis on artificial intelligence (AI), biomarkers and clocks, geroscience, and clinical trials and interventions for healthy longevity. Moreover, we provide an overview of academic research and the biotech industry focused on targeting ageing as the root of age-related diseases to combat multimorbidity and extend healthspan. We propose that the integration of generative AI, cutting-edge biological technology, and longevity medicine is essential for extending the productive and healthy human lifespan.

Sign up for free Altmetric alerts about this article - 
https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206135

Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts

Keywords - aging, biotechnology, artificial intelligence, healthy longevity

About Aging-US

The mission of the journal is to understand the mechanisms surrounding aging and age-related diseases, including cancer as the main cause of death in the modern aged population.

The journal aims to promote 1) treatment of age-related diseases by slowing down aging, 2) validation of anti-aging drugs by treating age-related diseases, and 3) prevention of cancer by inhibiting aging. (Cancer and COVID-19 are age-related diseases.)

Please visit our website at https://www.Aging-US.com​​ and connect with us:

Facebook - https://www.facebook.com/AgingUS/
X - https://twitter.com/AgingJrnl
Instagram - https://www.instagram.com/agingjrnl/
YouTube - https://www.youtube.com/@AgingJournal
LinkedIn - https://www.linkedin.com/company/aging/
Pinterest - https://www.pinterest.com/AgingUS/
Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc

Media Contact
18009220957
MEDIA@IMPACTJOURNALS.COM

Longevity & Aging Series (S3, E1): Dr. Yu-Xuan Lyu

Casey Lippmeier, Senior Vice President of Innovation at Conagen speaks with Daphne Preuss, CEO at Natáur and Frank Turano, Chief Research Officer at Natáur to discuss the world of bio-based Taurine, an essential nutrient for humans and animals used in everyday products, such as infant formula, pet food, animal feed, nutrition supplements, personal-care products, and perhaps most famously, in energy drinks.

Learn more about Natáur at natáur.com

Natáur's Bio-based Taurine

Wisdom Research Evolution @avexacortexa 
1:1 like no other 

@searingthrume
@yuracual

I. bare skin 
| https://soundcloud.com/dancinginrainfall/skin |
II. cant understand / difebarbamate
III. no personnel / indapyrophenidone
IV. 1-(1-Ethynylcyclohexyl)piperidine [YNCP]
V. dexoxadrol | delucemine
VI. your lovely skin 
| https://soundcloud.com/dancinginrainfall/enamored |
VII. pyeazolam | clobromazolam
VIII. DSP-0038 [ https://en.wikipedia.org/wiki/DSP-0038 ]
IX. HOCPCA | 39x Affinty
X. barbara i gongini | entangled with dread
XI. ICI-190,622
XII. dalmane / doriden [ gluthimide | flurazepam ]
| https://soundcloud.com/dancinginrainfall/oblivion |
XIII. calcium ion channel blockade
XVI. IHCH - 711 / GYKI - 52466 [ high bioavalibility | lipophilicity ]
XVII. α-pyrro​lidino​pentio​thiophenone
XVIII. epidermis piercer | pierce through me
XIX. [x] GABAA-rho w/ @lesioncovered
XX. Superagonist | Tetratonic Rippler Mk. 5
XXI. somnolence | α6β2γ2
XXII. [x] neurogenesis w/ @yuracual

netrunner research release: high affinity neuron depolarization | pharmacodynamics #avexacortexa

29. april 2025

I dag har vi med oss CEO Michael Engsig og Agnete Brunsvik Fredriksen, forskningsdirektør og ansvarlig for forretningsutvikling i Nykode. 

De forteller om siste måneds dramatikk i selskapet og hvordan veien blir videre.

Episode 327: Nykode Therapeutics

30. april 2025

I dag har vi med oss Sigrid Bratlie, strategisk rådgiver i Kreftforeningen og Langsikt - og ikke minst høyaktuell med bok om covid-pandemiens opphav: "Mysteriet i Wuhan". 

I dag er temaet celle-og genterapier, noe Sigrid kan mye om. Vi snakker om: Hva er det, hvilke behandlinger er godkjent, hva er flaskehalser og muligheter. Og vi snakker selvfølgelig mye om det norske forskningsmiljøet her, vårt porteføljeselskap Zelluna og; Karl-Johan Malmberg sin forskning som han i år er gitt  Kong Olav Vs kreftforskningspris av Kreftforeningen. Han for den for sitt arbeid med NK-celler, det vil si naturlig drepeceller.

Sigrid kommer tilbake i podkasten 11. juni. Da skal vi snakke om potensialet i kombinasjonen kunstig intelligens og bioteknologi, og hvilke implikasjoner det kan ha for kreftfeltet. 

Send oss gjerne spørsmål!

Episode 328: Celle- og genterapi med Sigrid Bratlie

Originally broadcast on The Dream Machine channel on www.intergalactic.fm on 16th June 2024.

FUTURE SOUND OF LONDON - Amoeba
GESCOM - Keynell 2
GLOBAL COMMUNICATION - 14:31
APHEX TWIN - On (µ-ziq Mix)
SUN ELECTRIC - R-Gent
AMORPHOUS ANDROGYNOUS - Pod Room
T-POWER - Bud
BOARDS OF CANADA - Telephasic Workshop

4-D TRAVELLER - Biological Machinery

Astellas is doubling down on gene therapy while others retreat. Richard Wilson, SVP Primary Focus Lead, Genetic Regulation at Astellas, joins In Vivo to discuss why the company believes AAV technology will transform medicine despite current industry headwinds.

🎯 Key Topics:
- Why Astellas opened a massive new gene therapy manufacturing facility
- Building an end-to-end AAV platform from research to commercial
- Strategic partnerships driving CNS and rare disease programs
- Maintaining team morale in a challenging investment climate
- Regulatory outlook and the path to commercial success

Richard also plays a role in Astellas' West Coast Innovation Center and serves on the Alliance for Regenerative Medicine board. He shares insights on manufacturing at scale, patient-centric culture, and the long-term potential of gene therapy.

Perfect for biotech investors, pharma executives, and anyone tracking the evolution of genetic medicines.

🔗 More insights: insights.citeline.com/in-vivo

Astellas Doubles Down on Gene Therapy Despite Industry Headwinds

From Plato and Derrida to anti-aging treatments, cryogenics, cloning, and whole-brain uploads, the dream of indefinite life is technological and, as Adam Rosenthal shows in Prosthetic Immortalities: a matter of prosthesis, the transformation of the original being. There can be no certainty of immortality and yet, the problem of immortality continues to haunt the soul. Rosenthal engages David Wills and Deborah Goldgaber in a conversation that touches on philosophy, transhumanism, biopolitics, Dolly the sheep and the return of the dire wolf, what it means to extend life or, ultimately, to extend death.


Adam R. Rosenthal is associate professor of French and global studies at Texas A&M University. Rosenthal is author of Prosthetic Immortalities: Biology, Transhumanism, and the Search for Indefinite Life and Poetics and the Gift: Reading Poetry from Homer to Derrida.

David Wills is professor of French studies at Brown University and author of Prosthesis. 

Deborah Goldgaber is assistant professor of philosophy at Louisiana State University and author of Speculative Grammatology: Deconstruction and the New Materialism.



REFERENCES:
Plato 
Homer
Descartes
Heidegger (the Dasein)
Derrida
Geoffrey Hinton
Hegel
Nick Bostrum
Dolly the sheep
David Chalmers
Aubrey de Grey
Jean-Baptiste Lamarck



Praise for the book:
“Rigorous, compelling, and beautifully written, Prosthetic Immortalities is at the vanguard of the new wave in Derrida studies.”
—Nicole Anderson, founding editor, Derrida Today Journal

“Adam R. Rosenthal conjures up the ghosts of metaphysics that return today through the promises of indefinite life from medical science and transhumanist speculations, moving brilliantly between science and science fiction.”
—Francesco Vitale, author of Biodeconstruction: Jacques Derrida and the Life Sciences



Prosthetic Immortalities: Biology, Transhumanism, and the Search for Indefinite Life by Adam R. Rosenthal, with foreword by David Wills, is available from University of Minneota Press. Thank you for listening.


The dream of indefinite life.

Avexa Cortexa Pharmeceutical & Biotech Research Facility

Wisdom Research Evolution

|  @avexacortexa
|  @traumacatalyst

1:1

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.

Conversations with bio visionaries and thought leaders on innovation in biotechnology, synthetic biology and biomanufacturing across food, beverage, nutritional, industrial materials, beauty and personal care spaces.

DDE is constantly working to provide smarter technologies, systems and solutions to healthcare companies. For the last 30 years, our focus has been to develop smarter innovations. Today, DDE houses 350+ engineers, technicians, designers, biotechnologists, researchers and experts working at the intersection of technology and healthcare sciences to solve some of the industry’s toughest problems.

Dresden-based Label for electronic listening music, inspired and dedicated to ambient, krautrock, kosmische/cosmic and experimental music.

Support us at bandcamp: www.permusicaadastra.bandcamp.com

Per Musica Ad Astra mix on every Sunday at 19:00 CET on www.intergalactic.fm (The Dream Machine channel).

Aging-US is dedicated to advancing our understanding of the biological mechanisms that drive aging and the development of age-related diseases. Our mission is to serve as a platform for high-quality research that uncovers the cellular, molecular, and systemic processes underlying aging, and translates these insights into strategies to extend healthspan and delay the onset of chronic disease.

Read about the Aging (Aging-US) Scientific Integrity Process: https://aging-us.com/scientific-integrity

Radium er en podkast som utgis av RADFORSK. I studio snakker Elisabeth Andersen og Jónas Einarsson om siste nytt innen kreftforskning og utvikling av ny kreftbehandling og porteføljebedriftene til RADFORSK - alene eller sammen med gjester.

The Lumen Christi Institute for Catholic Thought was founded by Catholic scholars at the University of Chicago in 1997 to bring the light of Christ and the Catholic intellectual and spiritual tradition to the secular academy and the general public. On this station we make available our many lectures and programs, as well as interviews with visiting scholars.

To support our work, visit www.lumenchristi.org/donate

Markus Raupach arbeitete als Fotograf, Journalist und Medienprofi schon bald nach der Gründung seiner Medienagentur 1998 für Brauereien, Hotels und Gastronomien. Seit 2005 erschienen zudem 40 Bücher aus der Feder des Bambergers, darunter auch Brauereiführer für Franken, Bayern, Sachsen, Thüringen und Berlin. Aus zahlreichen Veranstaltungen, die er seit 2006 organisierte, entstand schließlich die Idee einer BierAkademie, die er 2013 mit der Gründung der Deutschen BierAkademie verwirklichte, wofür er mit der “Goldenen BierIdee 2015” ausgezeichnet wurde. 2019 erhielt er diese Auszeichnung erneut, diesmal für die Realisierung seiner Idee eines “Walk of Beer” in Forchheim.

Markus Raupach ist Diplom Bier-, Edelbrand- und Käsesommelier, erfahrener Juror (u.a. European Beer Star, World Beer Cup, Brussels Beer Challenge, World Beer Awards, Brazilian Beer Contest, Champion Beer of Britain, Copa Cervezas de América, Meininger Craft Beer Award, Best Finish Beers Helsinki, Birra dell’Anno Rimini, KuBo Award Bozen, Rosglavpivo Beer Competition Moskau), Mitglied der British Guild of Beer Writers, der Master Brewers Association of Americas sowie Träger des Bamberger Bierordens, Vorstandsmitglied von Bierland Oberfranken und vom Verband der Bayerischen Edelbrandsommeliers. 2017 wählten Branchenvertreter Markus Raupach bei den TOP 50 Awards des Bier, Bars & Brauer Magazines zu einer der 50 bedeutendsten Bierpersönlichkeiten Deutschlands. Seit 2018 ist Markus Raupach zudem Dozent an der Genussakademie Bayern.

New tracks tagged #Biotechnology